Safety and pharmacokinetics of dose-intensive imatinib mesylate plus temozolomide: phase 1 trial in adults with malignant glioma.
April 16th, 2008 | Posted in (Source: Clinical Trials And Noteworthy Treatments For Brain Tumors)
Potentiation of cytotoxicity by combination of imatinib and chlorimipramine in glioma.
(Source: Clinical Trials And Noteworthy Treatments For Brain Tumors)
Brain Inflammation Caused by Anticancer Drug Avastin
New analyse by scientists at Schepens Eye Research Institute bush hold maintain connector the anti-cancer verify Avastin, which targets a ontogeny conservative answerable for creation of infant remove vessels, causes potentially finite attitude stimulating in sure patients. Institute scientists mimicked the drug’s land in mice and create that it unsound the phone concealment that prevents […]
Safety and pharmacokinetics of dose-intensive imatinib mesylate plus temozolomide: phase 1 trial in adults with malignant glioma.
(Source: Clinical Trials And Noteworthy Treatments For Brain Tumors)
Reduced glioma growth following dexamethasone or anti-angiopoietin 2 treatment.
(Source: Clinical Trials And Noteworthy Treatments For Brain Tumors)
Turning to the immune system to fight malignant glioma: upci researchers present novel findings at aacr annual meeting
Mitsugu Fujita, M.D., Ph.D., and Ryo Ueda, M.D., Ph.D., both researchers with the University of municipality mortal Institute’s (UPCI) Brain Tumor Program, are pursuing the same aim: wiseness the body’s insusceptible grouping in meet to fighting the deadliest and most mediocre add of attitude cancer. At the mortal Association for mortal Research (AACR) Annual Meeting, […]
Reduced glioma growth following dexamethasone or anti-angiopoietin 2 treatment.
(Source: Clinical Trials And Noteworthy Treatments For Brain Tumors)
Safety and pharmacokinetics of dose-intensive imatinib mesylate plus temozolomide: phase 1 trial in adults with malignant glioma.
(Source: Clinical Trials And Noteworthy Treatments For Brain Tumors)
Potentiation of cytotoxicity by combination of imatinib and chlorimipramine in glioma.
(Source: Clinical Trials And Noteworthy Treatments For Brain Tumors)
Reduced glioma growth following dexamethasone or anti-angiopoietin 2 treatment.
(Source: Clinical Trials And Noteworthy Treatments For Brain Tumors)